688526
vs
S
Shanghai Composite
688526
Over the past 12 months, Wuhan Keqian Biology Co Ltd has underperformed Shanghai Composite, delivering a return of +21% compared to the Shanghai Composite's +24% growth.
Stocks Performance
688526 vs Shanghai Composite
Performance Gap
688526 vs Shanghai Composite
Performance By Year
688526 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Wuhan Keqian Biology Co Ltd
Glance View
Wuhan Keqian Biology Co., Ltd. engages in the research, development, production, and sale of veterinary biological products. The company is headquartered in Wuhan, Hubei and currently employs 848 full-time employees. The company went IPO on 2020-09-22. The firm's main products are vaccines for swine and poultry. The firm mainly conducts its businesses within the China market.